Clinical Trial Update: Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses [Phase 3]

View source ↗

Summary

Phase 3b trial comparing Metvix NDL-PDT to Metvix c-PDT in actinic keratoses has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Metvix NDL-PDT
• Metvix c-PDT

Snippet

Sponsor: Galderma R&D | Conditions: Actinic Keratoses | Phase 3 | Status: COMPLETED | Results posted: 2020-12-10